Table3.DOCX by Zifeng Guo (4965628)

Table1.DOCX by Zifeng Guo (4965628)

Table4.DOCX by Zifeng Guo (4965628)

(A) Longitudinal sections of soleus immunostained using antiserum 46 to plectin by Patryk Konieczny (47697)

“…Note, the signal associated with longitudinal perinuclear structures was decreased in ple1 compared with ple1b fibers (arrows). …”

Lateral movement of the saddle relative to the equine spine in rising and sitting trot on a treadmill by A. Byström (5533262)

“…A mixed model was applied, with MAX as outcome, and T6 and S3 vertical position, rigid body rotation angles (roll, pitch, yaw) of the horse’s and rider’s pelvis, vertical ground reaction forces, saddle force, and rider position (rising in rising trot, sitting in rising trot or sitting in sitting trot) as explanatory variables. The least square means for MAX were 14.3 (SE 4.7) mm and 23.9 (SE 4.7) mm for rising and sitting in rising trot, and 20.3 (SE 4.7) mm for sitting trot. …”

EHEC-Hly-containing OMVs are internalized via dynamin-dependent endocytosis. by Martina Bielaszewska (79970)

“…Data are presented as means ± standard deviations from three independent experiments. …”

Changes in the Cell Viability of Tzb-refractory Cells Upon Pharmacological Modulation of Autophagosomes Formation/Function. by Alejandro Vazquez-Martin (75018)

“…The total number of LC3-positive autophagosomes per cell is notably decreased in 3-MA-treated TzbR cells. Images show representative portions of SKBR3 and TzbR cell cultures captured in different channels for LC3 (<i>red</i>) and Hoechst 33258 (<i>blue</i>) with a 20× objective, and merged on BD Pathway™ 855 Bioimager System using BD Attovision™ software. …”

Effects of <i>T</i>. <i>gondii</i> infection on fear memory consolidation in mice. by Fumiaki Ihara (4592044)

“…(C) Time course for fear extinction as revealed by the decreased freezing response in the extinction test. …”

Image_5_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Data_Sheet_1_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.docx by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Image_6_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Image_4_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Image_1_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Image_3_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

Image_2_Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.TIF by Cheng Ding (34937)

“…</p>Results<p>The incidence and mortality decreased in most of the HBCs. The AAPCs of incidence ranged between −4.0 (Indonesia) and −0.2% (DR Congo) (all p < 0.05). …”

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy by Alexander Lind (5221088)

“…Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. …”

Datasheet3_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Table1_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Datasheet2_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”

Datasheet4_Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials.docx by Chun Lin (680865)

“…According to the meta-analysis, catheter ablation significantly reduced all-cause mortality compared with drug therapy [9.2% vs. 14.1%, OR: 0.62, (95% CI: 0.47–0.82), P = 0.0007, I²= 0%], improved LVEF [MD: 5.65%, (95% CI: 3.32–7.98), P < 0.00001, I²= 86%], reduced AF recurrence [41.6% vs. 61.9%, OR: 0.23, (95% CI: 0.11–0.48), P < 0.0001, I²= 82%], decreased the MLHFQ score [MD: −6.38, (95% CI: −11.09 to −1.67), P = 0.008, I²= 64%] and increased 6MWD [MD: 17.55, (95% CI: 15.77–19.33), P < 0.0001, I²= 37%]. …”